Zillion announced today that it partnered with Dexcom (Nasdaq:DXCM) to integrate its CGM technology with Zillion’s digital health platform.

Needham, Massachusetts-based Zillion will connect Dexcom’s continuous glucose monitoring (CGM) platform with its digital health offering for the RestoreHealth program, enhancing RestoreHealth for employer and health system patients.

“Type 2 diabetes continues to be a growing health problem. At Zillion, our goal is to develop programs to improve individual health outcomes, as well as reduce medical expenses,” Zillion President and CEO Cheryl Morrison Deutsch said in a news release. “We’re excited to partner with Dexcom to provide patients with the data they need to take control of their health and experience real improvements that help them live happier and healthier lives.”

RestoreHealth features personalized, actionable support for employees that address health issues before they escalate. The company’s Zillion platform, a content-agnostic platform enabling organizations to deliver their programs through a tailored technology and services solution.

Zillion CMO Dr. Cate Collings said that Dexcom’s CGM represents a technological improvement that helps RestoreHealth members and coaches proactively manage real-time health data to allow for adjustments to their plan of care.

According to Dr. Cate Collings, Chief Medical Officer for Zillion, CGM represents a technological improvement that helps RestoreHealth members and coaches proactively manage real-time health data to allow for adjustments to the plan of care.

“We have seen metabolic disease factor reduction with RestoreHealth,” Collings said. “In some cases, we have been able to successfully decrease disease incidence. We expect to see significant enhancement to these results with this partnership.”